 | • レポートコード：B-GIR09D4259 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、腎疾患治療の世界市場について調べ、まとめました。種類別セグメントは、急性腎障害、慢性腎疾患、その他等、用途別セグメントは、病院、診療所、研究センター、その他等に区分しました。腎疾患治療の世界市場概観、企業動向、企業別腎疾患治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・腎疾患治療の市場概観 ・腎疾患治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・腎疾患治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・腎疾患治療の世界市場規模 ・腎疾患治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・腎疾患治療のアメリカ市場規模推移 ・腎疾患治療のカナダ市場規模推移 ・腎疾患治療のメキシコ市場規模推移 ・腎疾患治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・腎疾患治療のドイツ市場規模推移 ・腎疾患治療のイギリス市場規模推移 ・腎疾患治療のロシア市場規模推移 ・腎疾患治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・腎疾患治療の日本市場規模推移 ・腎疾患治療の中国市場規模推移 ・腎疾患治療の韓国市場規模推移 ・腎疾患治療のインド市場規模推移 ・腎疾患治療の東南アジア市場規模推移 ・腎疾患治療の南米市場分析（ブラジル、アルゼンチン等） ・腎疾患治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・腎疾患治療の種類別分析/販売量、売上、市場シェア（急性腎障害、慢性腎疾患、その他） ・腎疾患治療の用途別分析/市場規模（病院、診療所、研究センター、その他） ・腎疾患治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・腎疾患治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Renal Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Renal Disease Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Renal Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Renal Disease Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott
Amgen
Baxter
Bristol-Myers Squibb Company
Keryx Biopharmaceuticals
NephroGenex
Novartis AG
Pfizer
Sanofi
Shire Pharmaceuticals Limited
CTI BioPharma Corp
Merck
Prolong Pharmaceuticals
VESSL Therapeutics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Acute Kidney Problems
Chronic Kidney Diseases
Others
Market Segment by Applications, can be divided into
Hospital
Clinic
Research Center
Other
Table of Contents
1 Renal Disease Treatment Market Overview
1.1 Product Overview and Scope of Renal Disease Treatment
1.2 Classification of Renal Disease Treatment by Types
1.2.1 Global Renal Disease Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Renal Disease Treatment Revenue Market Share by Types in 2018
1.2.3 Acute Kidney Problems
1.2.4 Chronic Kidney Diseases
1.2.5 Others
1.3 Global Renal Disease Treatment Market by Application
1.3.1 Global Renal Disease Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Center
1.3.5 Other
1.4 Global Renal Disease Treatment Market by Regions
1.4.1 Global Renal Disease Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Renal Disease Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Renal Disease Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Renal Disease Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Renal Disease Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Renal Disease Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Renal Disease Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Renal Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Renal Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Baxter
2.3.1 Business Overview
2.3.2 Renal Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Baxter Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bristol-Myers Squibb Company
2.4.1 Business Overview
2.4.2 Renal Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bristol-Myers Squibb Company Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Keryx Biopharmaceuticals
2.5.1 Business Overview
2.5.2 Renal Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Keryx Biopharmaceuticals Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 NephroGenex
2.6.1 Business Overview
2.6.2 Renal Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 NephroGenex Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Novartis AG
2.7.1 Business Overview
2.7.2 Renal Disease Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis AG Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Pfizer
2.8.1 Business Overview
2.8.2 Renal Disease Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pfizer Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Sanofi
2.9.1 Business Overview
2.9.2 Renal Disease Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Shire Pharmaceuticals Limited
2.10.1 Business Overview
2.10.2 Renal Disease Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Shire Pharmaceuticals Limited Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 CTI BioPharma Corp
2.11.1 Business Overview
2.11.2 Renal Disease Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 CTI BioPharma Corp Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.12 Merck
2.12.1 Business Overview
2.12.2 Renal Disease Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Merck Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.13 Prolong Pharmaceuticals
2.13.1 Business Overview
2.13.2 Renal Disease Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Prolong Pharmaceuticals Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.14 VESSL Therapeutics
2.14.1 Business Overview
2.14.2 Renal Disease Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 VESSL Therapeutics Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Renal Disease Treatment Market Competition, by Players
3.1 Global Renal Disease Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Renal Disease Treatment Players Market Share
3.2.2 Top 10 Renal Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Renal Disease Treatment Market Size by Regions
4.1 Global Renal Disease Treatment Revenue and Market Share by Regions
4.2 North America Renal Disease Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Renal Disease Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Renal Disease Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Renal Disease Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Renal Disease Treatment Revenue and Growth Rate (2014-2019)
5 North America Renal Disease Treatment Revenue by Countries
5.1 North America Renal Disease Treatment Revenue by Countries (2014-2019)
5.2 USA Renal Disease Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Renal Disease Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Renal Disease Treatment Revenue and Growth Rate (2014-2019)
6 Europe Renal Disease Treatment Revenue by Countries
6.1 Europe Renal Disease Treatment Revenue by Countries (2014-2019)
6.2 Germany Renal Disease Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Renal Disease Treatment Revenue and Growth Rate (2014-2019)
6.4 France Renal Disease Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Renal Disease Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Renal Disease Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Renal Disease Treatment Revenue by Countries
7.1 Asia-Pacific Renal Disease Treatment Revenue by Countries (2014-2019)
7.2 China Renal Disease Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Renal Disease Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Renal Disease Treatment Revenue and Growth Rate (2014-2019)
7.5 India Renal Disease Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Renal Disease Treatment Revenue and Growth Rate (2014-2019)
8 South America Renal Disease Treatment Revenue by Countries
8.1 South America Renal Disease Treatment Revenue by Countries (2014-2019)
8.2 Brazil Renal Disease Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Renal Disease Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Renal Disease Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Renal Disease Treatment by Countries
9.1 Middle East and Africa Renal Disease Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Renal Disease Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Renal Disease Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Renal Disease Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Renal Disease Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Renal Disease Treatment Revenue and Growth Rate (2014-2019)
10 Global Renal Disease Treatment Market Segment by Type
10.1 Global Renal Disease Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Renal Disease Treatment Market Forecast by Type (2019-2024)
10.3 Acute Kidney Problems Revenue Growth Rate (2014-2024)
10.4 Chronic Kidney Diseases Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Renal Disease Treatment Market Segment by Application
11.1 Global Renal Disease Treatment Revenue Market Share by Application (2014-2019)
11.2 Renal Disease Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Research Center Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global Renal Disease Treatment Market Size Forecast (2019-2024)
12.1 Global Renal Disease Treatment Market Size Forecast (2019-2024)
12.2 Global Renal Disease Treatment Market Forecast by Regions (2019-2024)
12.3 North America Renal Disease Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Renal Disease Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Renal Disease Treatment Revenue Market Forecast (2019-2024)
12.6 South America Renal Disease Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Renal Disease Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Renal Disease Treatment Picture
Table Product Specifications of Renal Disease Treatment
Table Global Renal Disease Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Renal Disease Treatment Revenue Market Share by Types in 2018
Figure Acute Kidney Problems Picture
Figure Chronic Kidney Diseases Picture
Figure Others Picture
Table Global Renal Disease Treatment Revenue (Million USD) by Application (2014-2024)
Figure Renal Disease Treatment Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Research Center Picture
Figure Other Picture
Table Global Market Renal Disease Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Renal Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Renal Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Renal Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Renal Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Renal Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Renal Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Renal Disease Treatment Type and Applications
Table Abbott Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Renal Disease Treatment Type and Applications
Table Amgen Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Baxter Basic Information, Manufacturing Base and Competitors
Table Baxter Renal Disease Treatment Type and Applications
Table Baxter Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Company Renal Disease Treatment Type and Applications
Table Bristol-Myers Squibb Company Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Keryx Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Keryx Biopharmaceuticals Renal Disease Treatment Type and Applications
Table Keryx Biopharmaceuticals Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table NephroGenex Basic Information, Manufacturing Base and Competitors
Table NephroGenex Renal Disease Treatment Type and Applications
Table NephroGenex Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Renal Disease Treatment Type and Applications
Table Novartis AG Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Renal Disease Treatment Type and Applications
Table Pfizer Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Renal Disease Treatment Type and Applications
Table Sanofi Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Pharmaceuticals Limited Basic Information, Manufacturing Base and Competitors
Table Shire Pharmaceuticals Limited Renal Disease Treatment Type and Applications
Table Shire Pharmaceuticals Limited Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table CTI BioPharma Corp Basic Information, Manufacturing Base and Competitors
Table CTI BioPharma Corp Renal Disease Treatment Type and Applications
Table CTI BioPharma Corp Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Renal Disease Treatment Type and Applications
Table Merck Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Prolong Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Prolong Pharmaceuticals Renal Disease Treatment Type and Applications
Table Prolong Pharmaceuticals Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table VESSL Therapeutics Basic Information, Manufacturing Base and Competitors
Table VESSL Therapeutics Renal Disease Treatment Type and Applications
Table VESSL Therapeutics Renal Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Renal Disease Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Renal Disease Treatment Revenue Share by Players (2014-2019)
Figure Global Renal Disease Treatment Revenue Share by Players in 2017
Figure Global Renal Disease Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Renal Disease Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Renal Disease Treatment Revenue Market Share in 2018
Figure Global Renal Disease Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Renal Disease Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Renal Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Renal Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Renal Disease Treatment Revenue Market Share by Regions in 2018
Figure North America Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South America Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Table North America Renal Disease Treatment Revenue by Countries (2014-2019)
Table North America Renal Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Renal Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Renal Disease Treatment Revenue Market Share by Countries in 2018
Figure USA Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Table Europe Renal Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Renal Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Renal Disease Treatment Revenue Market Share by Countries in 2018
Figure Germany Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UK Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure France Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Renal Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Renal Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Renal Disease Treatment Revenue Market Share by Countries in 2018
Figure China Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure India Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Table South America Renal Disease Treatment Revenue by Countries (2014-2019)
Table South America Renal Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Renal Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Renal Disease Treatment Revenue Market Share by Countries in 2018
Figure Brazil Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Renal Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Renal Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Renal Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Renal Disease Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Renal Disease Treatment Revenue and Growth Rate (2014-2019)
Table Global Renal Disease Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Renal Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Renal Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Renal Disease Treatment Revenue Share by Type in 2019
Table Global Renal Disease Treatment Revenue Forecast by Type (2019-2024)
Figure Global Renal Disease Treatment Market Share Forecast by Type (2019-2024)
Figure Global Acute Kidney Problems Revenue Growth Rate (2014-2019)
Figure Global Chronic Kidney Diseases Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Renal Disease Treatment Revenue by Application (2014-2019)
Table Global Renal Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Renal Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Renal Disease Treatment Revenue Share by Application in 2019
Table Global Renal Disease Treatment Revenue Forecast by Application (2019-2024)
Figure Global Renal Disease Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Research Center Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Renal Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Renal Disease Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Renal Disease Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Renal Disease Treatment Revenue Market Forecast (2019-2024)
Figure Europe Renal Disease Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Renal Disease Treatment Revenue Market Forecast (2019-2024)
Figure South America Renal Disease Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Renal Disease Treatment Revenue Market Forecast (2019-2024)
世界のレフサム病治療市場予測（～2024年） Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. Scop…- 世界のアジソン病治療市場予測（～2024年） Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Symptoms generally come on slowly and may include abdominal pain, weakness, and weight loss. Darkening of the skin…
- 世界のバッテン病治療市場予測（～2024年） Batten disease is inherited disorder of the nervous system which begins in childhood.It is also called as neuronal ceroid lipofuscinoses (or NCLs). Batten Disease Treatment is the treatment of this type of disease. Scope of the Report: The global Batten Disease Treatment market is valued at xx milli…
- 世界の消失性骨疾患治療市場予測（～2024年） Vanishing bone disease or Gorham-stout syndrome is a rare skeletal disease characterized by progressive osteolysis and the proliferation of lymphatic vessels within the bone which leads to the destruction and absorption of bone. Additionally, the bones affected by the disease are more prone to osteo…
- 世界の珍炎症性疾患市場予測（～2024年） Scope of the Report: The global Rare Inflammatory Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…